Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.

J Virol 2016 10 12;90(19):8520-30. Epub 2016 Sep 12.

Department of Microbiology and Immunology, Fels Institute for Cancer Research, Temple University School of Medicine, Philadelphia, Pennsylvania, USA

Unlabelled: The latent infection of Epstein-Barr virus (EBV) is associated with 1% of human cancer incidence. Poly(ADP-ribosyl)ation (PARylation) is a posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) that mediate EBV replication during latency. In this study, we detail the mechanisms that drive cellular PARylation during latent EBV infection and the effects of PARylation on host gene expression and cellular function. EBV-infected B cells had higher PAR levels than EBV-negative B cells. Moreover, cellular PAR levels were up to 2-fold greater in type III than type I latently infected EBV B cells. We identified a positive association between expression of the EBV genome-encoded latency membrane protein 1 (LMP1) and PAR levels that was dependent upon PARP1. PARP1 regulates gene expression by numerous mechanisms, including modifying chromatin structure and altering the function of chromatin-modifying enzymes. Since LMP1 is essential in establishing EBV latency and promoting tumorigenesis, we explored the model that disruption in cellular PARylation, driven by LMP1 expression, subsequently promotes epigenetic alterations to elicit changes in host gene expression. PARP1 inhibition resulted in the accumulation of the repressive histone mark H3K27me3 at a subset of LMP1-regulated genes. Inhibition of PARP1, or abrogation of PARP1 expression, also suppressed the expression of LMP1-activated genes and LMP1-mediated cellular transformation, demonstrating an essential role for PARP1 activity in LMP1-induced gene expression and cellular transformation associated with LMP1. In summary, we identified a novel mechanism by which LMP1 drives expression of host tumor-promoting genes by blocking generation of the inhibitory histone modification H3K27me3 through PARP1 activation.

Importance: EBV is causally linked to several malignancies and is responsible for 1% of cancer incidence worldwide. The EBV-encoded protein LMP1 is essential for promoting viral tumorigenesis by aberrant activation of several well-known intracellular signaling pathways. We have identified and defined an additional novel molecular mechanism by which LMP1 regulates the expression of tumor-promoting host genes. We found that LMP1 activates the cellular protein PARP1, leading to a decrease in a repressive histone modification, accompanied by induction in expression of multiple cancer-related genes. PARP1 inhibition or depletion led to a decrease in LMP1-induced cellular transformation. Therefore, targeting PARP1 activity may be an effective treatment for EBV-associated malignancies.

Download full-text PDF

Source
http://jvi.asm.org/lookup/doi/10.1128/JVI.01180-16
Publisher Site
http://dx.doi.org/10.1128/JVI.01180-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021435PMC
October 2016
3 Reads

Publication Analysis

Top Keywords

gene expression
20
host gene
12
expression
12
cellular transformation
12
par levels
12
parp1
11
lmp1
9
expression parp1
8
cellular parylation
8
expression cellular
8
histone modification
8
mechanism lmp1
8
parp1 inhibition
8
cellular
8
parp1 activity
8
repressive histone
8
lmp1 essential
8
cancer incidence
8
protein lmp1
8
epstein-barr virus
8

References

(Supplied by CrossRef)
Infectious mononucleosis
N Engl J Med 2010

2007
The epigenetic life cycle of Epstein-Barr virus
Curr Top Microbiol Immunol 2015
Chromatin structure of Epstein-Barr virus latent episomes
Curr Top Microbiol Immunol 2015
The effect of poly(ADP-ribosyl)ation on native and H1-depleted chromatin
A role of poly(ADP-ribosyl)ation on core nucleosome structure. J Biol Chem 1989

Similar Publications